Skip to main content
Erschienen in: Clinical & Experimental Metastasis 2/2011

01.02.2011 | Research Paper

Transcriptional silencing of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon cancer cell line SW620

verfasst von: Qian Li, Hong Chen

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

N-Myc downstream-regulated gene 1 (NDRG1) plays vital roles in tumor metastasis suppression and is frequently silenced in metastatic colon cancers. NDRG1 is silenced in a highly metastatic colon cancer cell line SW620. The objective of this study was to investigate the potential mechanisms involved in silencing of the NDRG1 gene. SW480 and SW620 are two colon cancer cell lines established from the same patient with different metastatic potentials, making them an ideal model for investigation of metastatic mechanisms. Knockdown of NDRG1 in SW480 to a level that is similar to that in SW620 also modulated cell cycle and proliferation in SW480 towards the status of the highly metastatic SW620. Epigenetic mechanisms of the transcriptional control of NDRG1 were investigated. The silencing of NDRG1 in SW620 was not due to promoter hyper-methylation as bisulfite sequencing of the NDRG1 promoter showed minimal DNA methylation in both cell lines. On the other hand, chromatin immunoprecipitation showed a significantly higher level of RNA polymerase II (Pol II) association with the NDRG1 promoter in SW480 compared to SW620, in agreement with its gene expression level. The low Pol II binding at the NDRG1 promoter in SW620 was associated with gene-wide decrease in histone H4 acetylation and increase in histone H3 serine 10 phosphorylation. Meanwhile, the NDRG1 coding region showed much higher histone H3 lysine 4 methylation in SW480. In conclusion we observed unique histone modifications in two colon cancer cell lines with different metastatic potentials, indicating possible mechanisms for the down-regulation of NDRG1 in metastatic SW620.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Stafford LJ, Vaidya KS, Welch DR (2008) Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 40(5):874–891CrossRefPubMed Stafford LJ, Vaidya KS, Welch DR (2008) Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 40(5):874–891CrossRefPubMed
2.
Zurück zum Zitat Columbus J, Chiang Y, Shao W et al (2010) Insulin treatment and high fat diet feeding reduces the expression of three TCF genes in rodent pancreas. J Endocrinol 207(1):77–86CrossRefPubMed Columbus J, Chiang Y, Shao W et al (2010) Insulin treatment and high fat diet feeding reduces the expression of three TCF genes in rodent pancreas. J Endocrinol 207(1):77–86CrossRefPubMed
3.
Zurück zum Zitat Chiang AC, Massagu J (2010) Molecular basis of metastasis. N Engl J Med 359(26):2814–2823CrossRef Chiang AC, Massagu J (2010) Molecular basis of metastasis. N Engl J Med 359(26):2814–2823CrossRef
4.
Zurück zum Zitat Ellen TP, Ke Q, Zhang P et al (2008) NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29(1):2–8CrossRefPubMed Ellen TP, Ke Q, Zhang P et al (2008) NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29(1):2–8CrossRefPubMed
5.
Zurück zum Zitat Kurdistani SK, Arizti P, Reimer CL et al (1998) Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 58(19):4439–4444PubMed Kurdistani SK, Arizti P, Reimer CL et al (1998) Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 58(19):4439–4444PubMed
6.
Zurück zum Zitat Bandyopadhyay S, Pai SK, Hirota S et al (2004) PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res 64(21):7655–7660CrossRefPubMed Bandyopadhyay S, Pai SK, Hirota S et al (2004) PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res 64(21):7655–7660CrossRefPubMed
7.
Zurück zum Zitat Bandyopadhyay S, Wang Y, Zhan R et al (2006) The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res 66(24):11983–11990CrossRefPubMed Bandyopadhyay S, Wang Y, Zhan R et al (2006) The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res 66(24):11983–11990CrossRefPubMed
8.
Zurück zum Zitat Guan RJ, Ford HL, Fu Y et al (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60(3):749–755PubMed Guan RJ, Ford HL, Fu Y et al (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60(3):749–755PubMed
9.
Zurück zum Zitat Strzelczyk B, Szulc A, Rzepko R et al (2009) Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Ann Surg Oncol 16(5):1287–1294CrossRefPubMed Strzelczyk B, Szulc A, Rzepko R et al (2009) Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Ann Surg Oncol 16(5):1287–1294CrossRefPubMed
10.
Zurück zum Zitat Kim KT, Ongusaha PP, Hong YK et al (2004) Function of Drg1/Rit42 in p53-dependent mitotic spindle checkpoint. J Biol Chem 279(37):38597–38602CrossRefPubMed Kim KT, Ongusaha PP, Hong YK et al (2004) Function of Drg1/Rit42 in p53-dependent mitotic spindle checkpoint. J Biol Chem 279(37):38597–38602CrossRefPubMed
11.
Zurück zum Zitat Stein S, Thomas EK, Herzog B et al (2004) NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279(47):48930–48940CrossRefPubMed Stein S, Thomas EK, Herzog B et al (2004) NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279(47):48930–48940CrossRefPubMed
12.
Zurück zum Zitat Park H, Adams MA, Lachat P et al (2000) Hypoxia induces the expression of a 43 kDa protein (PROXY-1) in normal and malignant cells. Biochem Biophys Res Commun 276(1):321–328CrossRefPubMed Park H, Adams MA, Lachat P et al (2000) Hypoxia induces the expression of a 43 kDa protein (PROXY-1) in normal and malignant cells. Biochem Biophys Res Commun 276(1):321–328CrossRefPubMed
13.
Zurück zum Zitat Salnikow K, Costa M, Figg WD et al (2000) Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res 60(20):5630–5634PubMed Salnikow K, Costa M, Figg WD et al (2000) Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res 60(20):5630–5634PubMed
14.
Zurück zum Zitat Zhang P, Tchou-Wong KM, Costa M (2007) Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res 67(19):9125–9133CrossRefPubMed Zhang P, Tchou-Wong KM, Costa M (2007) Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res 67(19):9125–9133CrossRefPubMed
15.
Zurück zum Zitat Shimono A, Okuda T, Kondoh H (1999) N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 83(1–2):39–52CrossRefPubMed Shimono A, Okuda T, Kondoh H (1999) N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 83(1–2):39–52CrossRefPubMed
16.
Zurück zum Zitat Zhang J, Chen S, Zhang W et al (2008) Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region. Gene 417(1–2):5–12CrossRefPubMed Zhang J, Chen S, Zhang W et al (2008) Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region. Gene 417(1–2):5–12CrossRefPubMed
17.
Zurück zum Zitat Esteller M (2005) DNA methylation, epigenetics and metastasis. Springer, New YorkCrossRef Esteller M (2005) DNA methylation, epigenetics and metastasis. Springer, New YorkCrossRef
18.
Zurück zum Zitat Leibovitz A, Stinson JC, McCombs WB III et al (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36(12):4562–4569PubMed Leibovitz A, Stinson JC, McCombs WB III et al (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36(12):4562–4569PubMed
19.
Zurück zum Zitat Hewitt RE, McMarlin A, Kleiner D et al (2000) Validation of a model of colon cancer progression. J Pathol 192(4):446–454CrossRefPubMed Hewitt RE, McMarlin A, Kleiner D et al (2000) Validation of a model of colon cancer progression. J Pathol 192(4):446–454CrossRefPubMed
20.
Zurück zum Zitat Chen H, Pan YX, Dudenhausen EE et al (2004) Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region/leucine zipper transcription factors as well as localized histone acetylation. J Biol Chem 279(49):50829–50839CrossRefPubMed Chen H, Pan YX, Dudenhausen EE et al (2004) Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region/leucine zipper transcription factors as well as localized histone acetylation. J Biol Chem 279(49):50829–50839CrossRefPubMed
21.
Zurück zum Zitat Jiang K, Shen Z, Ye Y et al (2010) A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1). Scand J Gastroenterol 45(7–8):898–908CrossRefPubMed Jiang K, Shen Z, Ye Y et al (2010) A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1). Scand J Gastroenterol 45(7–8):898–908CrossRefPubMed
22.
Zurück zum Zitat Ganepola GA, Mazziotta RM, Weeresinghe D et al (2010) Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors. Clin Exp Metastasis 27(1):1–9CrossRefPubMed Ganepola GA, Mazziotta RM, Weeresinghe D et al (2010) Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors. Clin Exp Metastasis 27(1):1–9CrossRefPubMed
23.
Zurück zum Zitat Angst E, Dawson DW, Nguyen A et al (2010) Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells. Pancreas 39(5):675–679CrossRefPubMed Angst E, Dawson DW, Nguyen A et al (2010) Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells. Pancreas 39(5):675–679CrossRefPubMed
24.
Zurück zum Zitat Shahbazian MD, Grunstein M (2007) Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76:75–100CrossRefPubMed Shahbazian MD, Grunstein M (2007) Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76:75–100CrossRefPubMed
25.
Zurück zum Zitat Barski A, Cuddapah S, Cui K et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129(4):823–837CrossRefPubMed Barski A, Cuddapah S, Cui K et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129(4):823–837CrossRefPubMed
26.
Zurück zum Zitat Nowak SJ, Corces VG (2004) Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 20(4):214–220CrossRefPubMed Nowak SJ, Corces VG (2004) Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 20(4):214–220CrossRefPubMed
27.
Zurück zum Zitat Johansen KM, Johansen J (2006) Regulation of chromatin structure by histone H3S10 phosphorylation. Chromosome Res 14(4):393–404CrossRefPubMed Johansen KM, Johansen J (2006) Regulation of chromatin structure by histone H3S10 phosphorylation. Chromosome Res 14(4):393–404CrossRefPubMed
Metadaten
Titel
Transcriptional silencing of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon cancer cell line SW620
verfasst von
Qian Li
Hong Chen
Publikationsdatum
01.02.2011
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 2/2011
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-010-9366-4

Weitere Artikel der Ausgabe 2/2011

Clinical & Experimental Metastasis 2/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.